Spinal cord injury research hampered by animal models, says new study

“Despite decades of animal experiments, we still don’t have a drug to cure spinal cord injury in humans,” says Aysha Akhtar, a neurologist with PCRM and the lead author. “According to the Journal of the American Paraplegic Society, at least 22 agents were found to improve spinal cord injury in animals, but not one of these was helpful in humans,” says Dr. Akhtar.

The paper outlines the numerous problems with translating animal data into effective human treatments, including the many variations between laboratory-induced injuries in animals and human injuries, the difficulties in interpreting functional outcomes in animals, and the multitude of inter-species differences in physiology and anatomy.

The extrapolation problem, in general, has been widely acknowledged by scientists of many disciplines and affiliations. According to data from the Food and Drug Administration, more than 90 percent of drugs that proved successful in animal tests are not approved for wider use after clinical trials in humans. In February, three U.S. government agencies, including the National Institutes of Health, the Environmental Protection Agency, and the National Toxicology Program announced a major new program aimed at ending the use of animals in safety testing of new chemicals and drugs.

Because of the extrapolation challenge, some fields, such as cancer research and toxicity testing, are moving toward a greater use of alternatives. Unfortunately, spinal cord research, a relatively newer endeavor, is not yet learning from the failure of other fields of inquiry. As Dr. Akhtar warns, “We need to develop new, more effective research techniques.”

Although scientists have just begun to develop alternatives to the use of animals in spinal cord injury research, several techniques show great promise. Researchers at the University of Miami, for example, are collaborating on the Human Spinal Cord Injury Model Project which uses imaging techniques, post-mortem analysis, and nerve conduction methods to understand human spinal cords. Other promising directions involve computer modeling, studies on human nerve tissues, and the study of human cadavers.

At least 250,000 Americans are living with spinal cord injuries; an estimated 10,000 Americans are diagnosed each year.

Source: Physicians Committee for Responsible Medicine

Wake up and smell the coffee: Study finds that caffeine may help prevent MS
A good cup of coffee might be just the wake-up call scientists need to stop multiple sclerosis.
Umbilical cord blood cell transplants may help ALS patients
Moderate dose proves most effective in mouse model
A study at the University of South Florida has shown that transplants of mononuclear human umbilical cord blood (MNChUCB) cells may help patients suffering from Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig's disease. A disease in which the motor neurons in the spinal cord and brain degenerate, ALS leaves its victims with progressive muscle weakness, paralysis and, finally, respiratory failure three to five years after diagnosis.
Worm-like marine animal providing
The marine invertebrate amphioxus offers baseline information for genetic roots of vertebrate innovation such as the adaptive immune system
Research on the genome of a marine creature led by scientists at Scripps Institution of Oceanography at UC San Diego is shedding new light on a key area of the tree of life.
Engineer develops detergent to promote peripheral nerve healing
A detergent solution developed at The University of Texas at Austin that treats donor nerve grafts to circumvent an immune rejection response has been used to create acellular nerve grafts now used successfully in hospitals around the country. Research also shows early promise of the detergent solution having possible applications in spinal cord repair.
Origins of the brain: Complex synapses drove brain evolution
One of the great scientific challenges is to understand the design principles and origins of the human brain. New research has shed light on the evolutionary origins of the brain and how it evolved into the remarkably complex structure found in humans.
Human stem cells show promise against fatal children's diseases
Scientists have used human stem cells to dramatically improve the condition of mice with a neurological condition similar to a set of diseases in children that are invariably fatal, according to an article in the June issue of the journal Cell Stem Cell.
Neurologically impaired mice improve after receiving human stem cells
Scientists report a dramatic success in what may be the first documented rescue of a congenital brain disorder by transplantation of human neural stem cells. The research, published by Cell Press in the June issue of the journal Cell Stem Cell, may lead the way to new strategies for treating certain hereditary and perinatal neurological disorders.
Mind over matter: Monkey feeds itself using its brain
A monkey has successfully fed itself with fluid, well-controlled movements of a human-like robotic arm by using only signals from its brain, researchers from the University of Pittsburgh School of Medicine report in the journal Nature. This significant advance could benefit development of prosthetics for people with spinal cord injuries and those with “locked-in” conditions such as Lou Gehrig’s disease, or amyotrophic lateral sclerosis.

Spinal cord injury research hampered by animal models, says new study

Related stories:

News discussion: